Member Info for HelloSanDiego

The capacity is irrelevant if nobody is signing up for it.

It sounds like they haven't revealed how many people have actually signed up for it. There's another red flag then.

Were any STC subscriber numbers revealed in yesterday's presentation?

Chesh, there are dozens of companies where you could have tripled your money in the past 12 months.

I really don't see what reason you have to be so confident in this company.

expatbrat - "I continue to be correct in my forecasts and opinion on VLS..."

I haven't seen you make any forecasts, let alone correct ones. Can you point to any specific comments to back that up? Your opinion just amounts to "VLS won't succeed" and that is currently unknown.

Newuncle - "There is no clarity because Gerry does not know."

I disagree. I just think he either underestimated and understated the scale of the project, or for some reason it's become unachieveable and he's hoping that if he can drag it out long enough, other, future successes will hopefully appease investors.

In fairness to him, considering the challenges of developing, manufacturing and distributing a product of this scope there was no way this year was a possibility.

But if it really is being managed properly there's no reason not to be clear with investors (current and prospective) and give precise details about what the plan is and how they expect to achieve it. Otherwise it just looks increasingly doubtful they ever will.

muggins was right (15:50 yesterday) - the breath test HAS been delayed until next year. Here's a link to the part where that's revealed:

https://youtu.be/lQOpoEzAZpc?t=1353

That really should have been RNSd. This time last year half the company's market cap rested on it, and it was less than three weeks ago that Gerard reiterated on here that it was still on track to be rolled out this year.

25th August - gjbrandon: "...with potential roll-out of COVID-19 and other pathogen breath tests later this year."

Some clarity here would go a long way in restoring investor's confidence, in my opinion. What are the new tests they've decided to add? When are they due to be completed? How many participants are currently recruited and how many total?

mugginsthedog - "I think that I heard that the breathalyser is deferred until next year"

Can anyone confirm this?

How can you be sure Chesh?

I think it's a cache issue. I'm not sure if it's server or client side, but changing the "Posts per page"on the top-right a few times normally fixes it in my experience.

Final Result - Wed, 30th Jun - RNS Number : 7313D

"Subject to successful completion of additional human trials, the Microtox BT would be expected to meet the criteria for UK, MHRA's Target Product Profile Rapid Breath Test with potential roll out of COVID-19 and other pathogen breath tests later this year"

https://www.lse.co.uk/rns/DVRG/final-results-kzxfobi2df4cxey.html

The breathalyser was barely mentioned. I would have expected a ton of news if it's on track to be out in less than four months.

I found his quote from the interview. It's from the April 30th 2021 interview that was announced on that day's RNS. I think this is word-for-word and it's the latest official news I've seen about production and supply.

Q: Can you tell us about scale up and device providers?
RM: Aerogen already made to scale. We're working with them to ensure they have enough devices to meet demand for the drug in the second half of this year. On the drug product manufacturing we've got an aim to be able to produce 100k treatments per month and we're validating all the manufacturing steps to do that at the moment and we're building inventory as we go along. The P3 trial is likely to readout in the second half of this year.

Docdaneeka - "We know they've tested the supply line and made enough for the trials but nothing more"

Do we know that?

Late last year Richard Marsden gave an interview where he said to expect 100k treatments being produced per month throughout this year. Then I think there was one around February (this year) where he suggested it was taking a little longer than expected but was still largely on track. So has there been anything confirming they've only made enough for the trials or is that just an assumption?

Also, it was my understanding that British Airways' parent company had warrants over 50% of the Immingham plant, and I don't think they'll struggle to raise the capital when the time is right.

They're making steady progress doing what they're supposed to, and successfully financing it. It's a fact this company could be worthless in ten years. Or alternatively it could be worth billions, so the risk reflects the possible reward. If you expect its cash flow to mirror that of a gas and oil explorer you've got the wrong idea.

And as I said months ago, it looks like they're waiting for some good news at COP26 to lift the price before the next fundraise, and I think that looks even more likely now.

The problem is I already crossed my fingers. So how will I be sure that's not what made it happen?

If we get that RNS on Thursday it could actually be enough to convince me charts are more reliable than tarot cards. It's a long shot, but fingers crossed (because I'm reliably informed that can affect the outcome).

Maybe they just let slip details of projects they haven't formally announced yet.

https://www.whitehouse.gov/briefing-room/statements-releases/2021/09/09/fact-sheet-biden-administration-advances-the-future-of-sustainable-fuels-in-american-aviation/